The U.S. Food and Drug Administration on Monday expanded the emergency use authorization for Pfizer's COVID-19 vaccine boosters to children ages 12 to 15.

The agency also shortened the time needed before receiving a booster shot from at least six months after completion of the initial series to at least five months, for everyone 12 and older.

"Throughout the pandemic, as the virus that causes COVID-19 has continuously evolved, the need for the FDA to quickly adapt has meant using the best available science to make informed decisions with the health and safety of the American public in mind," FDA Acting Commissioner Dr. Janet Woodcock said in a statement. "With the current wave of the omicron variant, it's critical that we continue to take effective, life-saving preventative measures such as primary vaccination and boosters, mask wearing and social distancing in order to effectively fight COVID-19."

The U.S. Centers for Disease Control and Prevention on Tuesday backed the FDA's decision to shorten the interval between an initial series of Pfizer's vaccine and a booster shot, but plans to meet with their vaccine advisory board on Wednesday to discuss the issue of expanding booster eligibility to adolescents.... Read More: WBAL TV